Naples Global Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,800
Closed -$127K 449
2025
Q4
$127K Hold
10,800
0.01% 435
2025
Q3
$83.4K Hold
10,800
0.01% 434
2025
Q2
$78.9K Hold
10,800
0.01% 416
2025
Q1
$102K Buy
10,800
+100
+0.9% +$1.25K 0.01% 396
2024
Q4
$176K Hold
10,700
0.02% 400
2024
Q3
$158K Hold
10,700
0.01% 397
2024
Q2
$148K Hold
10,700
0.01% 387
2024
Q1
$168K Hold
10,700
0.02% 401
2023
Q4
$173K Hold
10,700
0.02% 402
2023
Q3
$132K Hold
10,700
0.02% 391
2023
Q2
$172K Hold
10,700
0.02% 392
2023
Q1
$186K Hold
10,700
0.02% 383
2022
Q4
$98.9K Hold
10,700
0.01% 384
2022
Q3
$92K Hold
10,700
0.01% 368
2022
Q2
$87K Hold
10,700
0.01% 372
2022
Q1
$130K Hold
10,700
0.02% 391
2021
Q4
$365K Hold
10,700
0.04% 320
2021
Q3
$516K Hold
10,700
0.07% 271
2021
Q2
$483K Hold
10,700
0.07% 266
2021
Q1
$516K Buy
10,700
+5,700
+114% +$297K 0.08% 256
2020
Q4
$269K Buy
+5,000
New +$226K 0.05% 317

Other funds holding NEO

Naples Global Advisors's NEO Position: Q1 2026 in Review

Naples Global Advisors sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 10,800 shares — an estimated $127K sold.

Naples Global Advisors first reported a position in NEO in Q4 2020 and held it in 21 quarters. The position peaked at $516K in Q3 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Naples Global Advisors reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Naples Global Advisors sold 10,800 NeoGenomics shares in Q1 2026, an estimated $127K.
  • Naples Global Advisors first reported a position in NeoGenomics in Q4 2020 and held it in 21 quarters.
  • Naples Global Advisors's NeoGenomics position peaked at $516K in Q3 2021.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Naples Global Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.